Effect of dexamethasone on elevated cytokine mRNA levels in chemical- induced hippocampal injury

Journal of Neuroscience Research

Volumn 57, Issue 6, 1999, Pages 916-926

  Bruccoleri, Alessandra ^a   Pennypacker, Keith R ^b   Harry, G Jean ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cytokines; Dexamethasone; GFAP; Hippocampus; Trimethyltin

Indexed keywords

CYTOKINE; DEXAMETHASONE; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; LYMPHOTOXIN; MESSENGER RNA; TRIMETHYLTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOSIS; BRAIN INJURY; CONTROLLED STUDY; GRANULE CELL; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CYTOKINES; DEXAMETHASONE; GLIOSIS; HIPPOCAMPUS; MALE; MICE; MICE, INBRED STRAINS; NECROSIS; NERVE DEGENERATION; NEUROTOXINS; RIBONUCLEASES; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRIMETHYLTIN COMPOUNDS;

EID: 0033568064     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990915)57:6<916::AID-JNR17>3.0.CO;2-J     Document Type: Article

References (74)

1. Abraham CR. 1992. The role of the acute-phase protein α1-antichymotrypsin in brain and injury. Res Immunol 143:631-636.
2. Almawi WY, Bayhum HN, Rahme AA, Reider MJ. 1996. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukocyte Biol 60:563-572.
3. Altman DI, Young RSK, Yagel SK. 1984. Effects of dexamethasone in hypoxia-ischemic brain injury in the neonatal rat. Biol Neonate 46:149-156.
4. Amano Y, Lee SW, Allison AC. 1993. Inhibition by glucocorticoids of the formation of interleukin-1α, interleukin-1β, and interleukin-6: mediation by decreased mRNA stability. Mol Pharmacol 43:176-182.
5. Barber A, Coyle S, Marano M, Fischer E, Calvano S, Fong Y, Moldawer L, Lowry SF. 1993. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 150:1999-2006.
6. Barks JD, Post M, Tuor UI. 1991. Dexamethasone prevents hypoxicischemic brain damage in the neonatal rat. Pediatric Res 29:558-563.
7. Barnes PJ. 1998. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci 94:557-572.
8. Bateman A, Singh A, Kral T, Solomon S. 1989. The immune-hypothalamic-pituitary-adrenal axis. Endoc.Rev 10:92-112.
9. Beutler B, Krochin N, Milsark IW, Leudke C, Cerami A. 1986. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232:977-979.
10. Boumpas DT, Anastassiou ED, Older SA, Tsokos GC, Nelson DL, Balow JE. 1991. Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J Clin Invest 87:1739-1747.
11. Brenner T, Yamin A, Abramsky O, Gallily R. 1993. Stimulation of tumor necrosis factor-α by mycoplasmas and inhibition by dexamethasone in cultured astrocytes. Brain Res 608:273-279.
12. Bruccoleri A, Brown H, Harry GJ. 1998. Cellular localization and temporal elevation of tumor necrosis factor-α, interleukin-1α, and transforming growth factor-α mRNA in hippocampal injury response induced by trimethyltin. J Neurochem 71:1577-1578.
13. Campbell IL, Hobbs MV, Kemper P, Oldstone MB. 1994. Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. J Immunol 152:716-723.
14. Carlos TM, Harlan M. 1994. Leukocyte-endothelial adhesion molecules. Blood 84:2068-2101.
15. Castano A, Lawson LJ, Fearn S, Perry VH. 1996. Activation and proliferation of murine microglia are insensitive to glucocorticoids in Wallerian degeneration. Eur J Neurosci 8:581-588.
16. Cato ACB, Wade E. 1996. Molecular mechanisms of anti-inflammatory action of glucocorticoids. BioEssays 18:371-378.
17. Chao CC, Hu S, Close K, Choi CS, Molitor TW, Novick WJ, Peterson PK. 1992. Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J Infectious Dis 166:847-853.
18. Chen HL, Romsos DR. 1996. Dexamethasone rapidly increases hypothalamic neuropeptide Y secretion in adrenalectomized ob/ob mice. Am J Physiol 271:E151-158.
19. Corder R, Pralong F, Turnill D, Saudan P, Muller AF, Gaillard RC. 1988. Dexamethasone treatment increased neuropeptide Y levels in rat hypothalamic neurones. Life Sci 43:1879-1886.
20. De Rijk R, Berkenbosch F. 1994. In: Grossman CJ, editor. Bilateral communication between the endocrine and immune system. New York: Springer-Verlag, p 73-95.
21. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. 1986. Induction by IL-1 and interferon, tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137:245-254.
22. Fathallah-Shaykh HM, Gao W, Cho M, Herrera MA. 1998. Priming in the brain, an immunologically privileged organ, elicits anti-tumor immunity. Int J Cancer 75:266-276.
23. Fitch MT, Silver J. 1997. Glial cell extracellular matrix: boundaries for axon growth in development and regeneration. Cell Tissue Res 290:379-384.
24. Frohman EM, Frohman TC, Dustin ML, Vayavegula B, Choi A, Gupta S, van den Noort, Gupta S. 1989. The induction of intercellular adhesion molecule-1 (ICAM-1) expression on human fetal astrocytes by interferon-γ, tumor necrosis factor-α, lymphotoxin, and interleukin-1: relevance to intercerebral antigen presentation. J Neuroimmunol 23:117-124.
25. Gelbard HA, James H.J, Sharer LR, Perry SW, Saito Y, Kazee AM, Blumberg BM, Epstein LG. 1995. Apoptotic neurons in brains from pediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol Appl Neurobiol 21:208-217.
26. Giulian D, Vaca K, Corpuz M. 1993. Brain glia release factors with opposing actions on neuronal survival. J Neurosci 13:29-37.
27. Goujon E, Laye S, Parnet P, Dantzer R. 1997. Regulation of cytokine gene expression in the central nervous system by glucocorticoids: mechanisms and functional consequences. Psychoneuroendrocrinology 22:S75-S80.
28. Guyre, PM, Girard MT, Morganelli PM, Manganiello PD. 1988. Glucocorticoid effects on the production and actions of immune cytokines. J Steroid Biochem 30:89-93.
29. Hall ED, Braughler JM. 1982. Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rationale. Surg Neurol 18:320-327.
30. Hallett MB, Lloyds D. 1995. Neutrophil priming: the cellular signals that say 'amber' but not green. Immunology Today 16:264-268.
31. Han J, Huez G, Beutler B. 1991. Interactive effects of the tumor necrosis factor promoter and 3′-untranslated regions. Immunology 146:1843-1848.
32. Han J, Thompson P, Beutler B. 1990. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 172:391-394.
33. Hess P, Payvar F. 1992. Hormone withdrawal triggers a premature and sustained gene activation from delayed secondary glucocorticoid response elements. J Biol Chem 267:3490-3497.
34. Hill MR, Stith RD, McCallum RE. 1986. Interleukin-1: a regulatory role in glucocorticoid-regulated hepatic metabolism. J Immunol 137:858-862.
35. Hobbs MV, Weigle WO, Noonan DJ, Torbett BE, McEvilly RJ, Koch RJ, Cardenas GJ, Ernst DN. 1993. Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J Immunol 150:3602-3614.
36. Hong J-H, Chiang C-S, Campbell IL, Sun J-R, Withers HR, McBride WH. 1995. Induction of acute phase gene expression by brain irradiation. Int J Radiation Oncol Biol Phys 33:619-626.
37. Inglis JD, Lee M, Davidson DR, Hill RE. 1991. Isolation of two cDNAs encoding novel alpha 1-antichymotrypsin-like proteins in a murine chondrocytic cell line. Gene 106:213-220.
38. Jefferies WM. 1994. Mild adrenocortical deficiency, chronic allergies, autoimmune disorders and the chronic fatigue syndrome: a continuation of the cortisone story. Med Hypotheses 42:183-189.
39. Kern JA, Lamb R, Reed J, Daniele R, Nowell PC. 1988. Dexamethasone inhibition of interleukin 1 beta production by human monocytes: post-transcriptional mechanisms. J Clin Invest 81:237-244.
40. Kiwerski JE. 1993. Application of dexamethasone in the treatment of acute spinal cord injury. Injury 24:457-460.
41. Knudsen PJ, Dinarello CA, Strom TB. 1987. Glucocorticoids inhibit transcription and post-transcriptional expression of interleukin-1. J Immunol 139:4129-4134.
42. Kutteh WH, Rainey WE, Carr BR. 1991. Glucocorticoids inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by human fetal Kupffer cells. J Clin Endocrinol Metab 73:296-301.
43. Lee SW, Tsuo A-P, Chan H, Thomas J, Petrie K, Eugui EM, Allison AC. 1988. Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc Natl Acad Sci USA 85:1204-1208.
44. Lees G. 1993. The possible contribution of microglia and macrophages to delayed neuronal death after ischemia. J Neurol Sci 114:119-122.
45. Leu W, Oppenheim JJ, Matsushima K. 1988. Analysis of the suppression of IL-1α and IL-1β production in human peripheral blood mononuclear cells by a glucocorticoid hormone. J Immunol 140:1895-1902.
46. Marlin SD, Springer TA. 1987. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51:813-819.
47. McEwen B, de Kloet E, and Rostene W. 1986. Adrenal steroid receptors and actions in the nervous system. Physiol Rev 66:1121-1167.
48. Mengozzi M, Fantuzzi G, Faggioni R, Marchant A, Goldman M, Orencole S, Clark BD, Sironi M, Benigni F, Ghezzi P. 1994. Chlorpromazine specifically inhibits peripheral and brain TNF production and up-regulates IL-10 production, in mice. Immunology 82:207-210.
49. Monick MM, Aksamit TR, Geist LJ, Hunninghake GW. 1994. Dexamethasone inhibits II-1 and TNF activity in human lung fibroblasts without affecting IL-1 or TNF receptors. Am J Physiol 267:L33-L38.
50. Munck A, Naray-Fejes-Toth A. 1994. Glucocorticoids and stress: permissive and suppressive actions. Ann N Y Acad Sci 746:115-130.
51. O'Callaghan JP, Brinton RE, McEwen BS. 1991. Glucocorticoids regulate the synthesis of glial fibrillary acidic protein in intact and adrenalectomized rats but do not affect its expression following brain injury. J Neurochem 57:860-869.
52. Pennypacker KR, Thai L, Hong J-S, McMillian MK. 1994. Prolonged expression of AP-1 transcription factors in the rat hippocampus after systemic kainate treatment. J Neurosci 14:3998-4006.
53. Pfister HW, Scheld WM. 1997. Brain injury in bacterial meningitis: therapeutic implications. Curr Opin Neurol 10:254-259.
54. Renz H, Hanke A, Hofmann P, Wolff LJ, Schmidt A, Ruschoff J, Gemsa D. 1992. Sensitization of rat alveolar macrophages to enhanced TNF alpha release by in vivo treatment with dexamethasone. Cell Immunol 144:249-257.
55. Rothlein R, Dustin ML, Marlin SD, Springer TA. 1986. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 137:1270-1274.
56. Sadamatsu M, Tsunashima K, Schwarzer C, Takahashi Y, Kato N, Sperk G. 1998. Trimethyltin-induced expression of neuropeptide Y Y2 receptors in rat dentate gyrus. Neurotoxicol Teratol 20:607-610.
57. Sapolsky R. 1985. A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults. J Neurosci 5:1228-1232.
58. Sapolsky RM. 1987. Glucocorticoids and hippocampal damage. Trends Neurosci 10:346-349.
59. Sapolsky RM, Pulsinelli WA. 1985. Glucocorticoids potentiate ischemic injury of neurons: therapeutic implications. Science 229: 1397-1400.
60. Schule R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma I, Evans RM. 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217-1226.
61. Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC. 1989. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 83:2008-2017.
62. Shrikant P, Chung IY, Ballestas M, Benveniste EN. 1994. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-α, interluekin-1β, and interferon-γ in astrocytes. J Neuroimmunol 51:209-222.
63. Shrikant P, Weber E, Jilling T, Benveniste EN. 1995. Intercellular adhesion molecule-1 gene expression by glial cells. Differential mechanisms of inhibition by IL-10 and IL-6. J Immunol 155:1489-1501.
64. Streit WJ, Kreutzberg GW. 1987. Lectin binding by resting and reactive microglia. J Neurocytol 16:249-260.
65. Tanaka J, Fujita H, Matsuda S, Toku K, Sakanaka M, Maeda N. 1997. Glucocorticoid-and mineralocorticoid receptors in microglial cells: the two receptor mediate differential effects of corticosteroids. Glia 20:23-37.
66. Tombaugh GC, Yang SH, Swanson RA, Sapolsky RM. 1992. Glucocorticoids exacerbate hypoxic and hypoglycemic hippocampal injury in vitro: biochemical correlates and a role for astrocytes. J Neurochem 59:137-146.
67. Tuor UI. 1997. Glucocorticoids and the prevention of hypoxicischemic brain damage. Neurosci Biobehav Rev 21:175-179.
68. Unlap T, Jope RS. 1994. Dexamethasone attenuates kainate-induced AP-1 activation in rat brain. Molec Brain Res 24:275-282.
69. Vezzani A, Sperk G, Colmers WF. 1999. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 22:25-30.
70. Villafuerte BC, Koop BL, Pao CI, Phillips LS. 1995. Glucocorticoid regulation of insulin-like growth factor-binding protein-3. Endocrinology 136:1928-1933.
71. Wei P, Inamdar N, Vedeckis WV. 1998. Transrepression of c-jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-jun promoter. Mol Endocrinol 12:1322-1333.
72. Wilckens T. 1995. Glucocorticoids and immune function: physiological relevance and pathogenic potential of hormonal dysfunction. Trends in Pharmacol Sci 16:193-197.
73. Yang-Yen H-F, Chambrand J-C, Sun, Y-L, Smeal T, Schmidt TJ, Drouin J, Karin M. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215.
74. Zuckerman SH, Shellhaas J, Butler LD. 1989. Differential regulation of lipopolysacharide-induced interleukin-1 and tumor necrosis factor synthesis: effects of endogenous glucocorticoids and the role of pituitary-adrenal axis. Eur J Immunol 19:301-305.